Mesothelioma Cancer is rare, affecting some 3,000 Americans and their families each year. Globally, the number of mesothelioma cases can reach ninety thousand. Because asbestos toxic chemicals, named "who" as carcinogenic Type 1 mesothelioma. While known health risks associated with asbestos for decades, are still used around the world in construction and manufacturing industries.
Mesothelioma Applied Research Foundation (Ombudsman) 's leading non-profit focused on mesothelioma awareness, education and advocacy research and treat patients. So far, has funded an average of $ 7.1 million in research projects on the treatment of mesothelioma, and examine closely the cancer related issues. One of the largest contributors are recently donating company Simmons $ 250,000, and got the diamond sponsor Prize "partner 2011 legal remedy".
Simmons company leading group mesothelioma litigation in Illinois Elton. Including the latest gift, Simmons Corporation donated $ 2.1 million to the Ombudsman. Simmons company enabled search continued though donated, but with the "annual International Symposium on malignant mesothelioma" to be held from 23 to 25 June 2011, in Washington, d.c..
Mesothelioma has a latency period and short-age patient after diagnosis. Mesothelioma develops in the lining of the lungs and other abdominal cavities. It takes 20 years to fifty to show symptoms, making it difficult to recognize. When the symptoms mimic those of pneumonia and bronchitis, the proper diagnosis is often delayed.
There are mesothelioma treatments available; helped surgery and chemotherapy treatments and radiological management life and prolonged pain to the patient. However, there is no cure for mesothelioma.
Referring to the support of the Ombudsman, "Mike angilidis" management partner company Simmons, backing "in medium-sized Tumor Foundation applied research and countless hours working to provide hope and awareness for mesothelioma community. Firm honored for making this contribution to support work that means a lot to our customers and all mesothelioma patients and families affected by this disease. "
Intermediate Foundation Executive Director Kathleen weidmir equally positive about the partnership with Simmons. The "finance research peer review and provide reliable medical expertise for all mesothelioma patients and their families from the fundamental purposes of the institution. Through the law firm Simmons leadership level support in our legal partners, 2011 will be well-positioned to continue our efforts to assist mesothelioma community, and promote awareness of this devastating disease and continue to support medical researchers working towards a cure ".
This entry was posted on Monday 28 February 2011 at 7: 58 pm and is filed under General. You can follow any responses to this entry through the RSS 2.0 feed. You can skip to the end and leave a response. Pinging is currently not allowed.
No comments:
Post a Comment